Quad Joins Bio-Techne to Provide Pioneering Solutions for Cell and Gene Therapy

In June of 2018, Quad Technologies was acquired by Bio-Techne. Our innovative GMP-manufactured Cloudz™ T Cell Activation Kit can be partnered with GMP ancillary reagents from Bio-Techne to enhance the safety, efficiency, and flexibility of ex vivo cell manufacturing.